Third Wave Tech expands gene analysis test portfolio
This article was originally published in Clinica
Executive Summary
Third Wave Technologies (TWT) is planning a fourth-quarter 2002 launch for its Invader DNA reagents for detecting mutations in the cystic fibrosis gene. The reagents are quicker, simpler and more accurate then conventional analysis methods, claims the firm.